Role of vascular endothelial growth factor in pathogenesis of rheumatoid arthritis

1. <div><p>Bresnihan В. Pathogenesis of joint damage in rheumatoid arthritis. J. Rheumatol., 1999, 26, 717-719</p><p>Сигидин Я.А., Лукина Г.В., Гусев Д.Е. О базисных свойствах глюкокортикоидов при ревматоидном артрите. Клинич. фармакол. и терап., 2000, 9 (1), 55-57</p><p>Беневоленская Л.И., Бржезовский М.М. Эпидемиология ревматических болезней. М., Медицина, 1988, 240</p><p>Каратеев Д.Е., Иванова М.М., Балабанова P.M., Акимова Т.Ф. Анализ летальных исходов ревматоидного артрита при длительном наблюдении. Росс, ревматол., 1998, 1. 17-28</p><p>Callahan L.F. The burden of rheumatoid arthritis: facts and figures. J. Rheumatol., 1998, 25 (suppl. 53), 8-12</p><p>Badley E.M. The economic burden of muscu-loskeletal disorders in Canada is similar to that for cancer, and may be higher. J. Rheumatol. 1995, 22, 202-206</p><p>Choy E.H.S., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med., 2001, 344, 12, 907-916</p><p>Koch A.E. The role of angiogenesis in rheumatoid arthritis: recent developments. Ann. Rheum. Dis., 2000, 59 (suppl. I), 65-71</p><p>Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1995, 1(1), 27-31</p><p>Koch A.E., Harlow L.A., Hainess G.K. et al. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol., 1994, 152, 4149-4156</p><p>FitzGerald O., Soden М., Yanni G. et al, Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann. Rheum. Dis., 1991, 50, 792-796</p><p>Lund-Olesen K. Oxygen tension in synovial fluids. Arthr. Rheum., 1970, 13, 769-776</p><p>Paleolog E.M. Angiogenesis in rheumatoid arthritis. Arthr. Res., 2002, 4 (suppl. 3), 81-90</p><p>Балабанова P.M., Иванова M.M., Каратеев Д.Е. Ревматоидный артрит на рубеже веков. В кн. Избранные лекции по клинической ревматологии. Насонова В.А., Бунчук Н.В. (ред.). М., Медицина, 2001, 61-67</p><p>Peacock D.J., Banquerigo M.L., Brahn Е. Angiogenesis inhibition supresses collagen arthritis. J. Exp. Med., 1992, 175, 1135-1138</p><p>Nagashima М., Yoshino S., Ishiwata T. et al. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J. Rheumatol., 1995, 22, 1624-1630</p><p>Sharkey A.M., Charnock-Jones D.S., Boocock C.A. et al. Expression of mRNA for vascular endothelial growth factor in human placenta. J. Reprod. Fertil., 1993, 99, 609-615</p><p>Brown L.F., Berse B., Tognazzi K. et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int., 1992, 42, 1457-1461</p><p>Houck K.A., Ferrara N., Winer J. et al. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 1991, 5, 1806-1814</p><p>Paleolog E.M., Young S., Stark A.C. et al. Modulationon angiogenic of vascular endothelial growth factor (VEGF) by TNF-a and IL-lin rheumatoid arthritis. Arthr. Rheum., 1998, 41, 1258-1265</p><p>Harada S., Nagy J.A., Sullivan K.A. et al. Induction of vascular endothelial growth factor expression by prostaglandin E2 and El in osteoblasts. J. Clin. Inves., 1994, 93, 24902496</p><p>Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med., 1999, 77, 527-543</p><p>Koch A.E., Polverini P.J., Leibovich S.J. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthr. Rheum., 1986, 29, 471-479</p><p>Veikkola Т., Alitalo K. VEGFs, receptors and angiogenesis. Semin. Cancer Biol., 1999, 9(3), 211-220</p><p>Ballara S., Taylor P.C., Paleolog E.M. et al. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthr. Rheum., 2001, 44 (9), 2055-2064</p><p>Paleolog E.M. Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target. Angiogenesis, 1998, 2 (4), 295-307</p><p>Cho C.S., Cho M.L., Min S.Y. et al. CD 40 engagement on synovial fibroblast upregulates expression of vascular endothelial growth factor. Arthr. Rheum., 1999, 42, S397</p><p>Taylor P., Miotla J.M., Etherington P. et al. VEGF release is associated with hypoxia in infflammatory arthritis (abstract). Arthr. Rheum., 2000, 43, (suppl. 9), 296</p><p>Nakahara H., Song J., Sugimoto M. et al. Anti-interleukin- 6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthr. Rheum., 2003, 48 (6), 1521-1529</p><p>Edwards C.J., Paleolog E.M., Brennan F.M. et. al. Contrasting effects of TGF-pi and BMP-2/4; regulators of vascular endothelial growth factor in rheumatoid arthritis. Arthr. Rheum., 1999, 42, S91</p><p>Mason J.C., Lidington E.A., Yarwood H. et al. Endothelial cell decay-accelerating factor (DAF) is induced by vascular endothelial growth factor (VEGF), is cytoprotective against activated complement and may be involved in regulating endothelial cell proliferating in chronic synovitis. Arthr. Rheum., 1999, 42, S397</p><p>Brooks P.C., Clark R.A., Cheresh D.A. Requirement of vascular integrin alpha V beta 3 for angiogenesis. Science, 1994, 264, 569-571</p><p>Fraser A., Fearon U., Reece R. et al. Matrix metallopro- teinase 9, apoptosis, and vascular morphology in early arthritis. Arthr. Rheum., 2001, 44 (9), 2024-2028</p><p>Latour F., Zabraniecki L., Dromer C. et al. Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological, and pathological study in patients monitored for 10 yars. Joint Bone Spine, 2001, 68 (6), 493-498</p><p>Каратеев Д.Е., Раденска-Лоповок С.Г., Насонова В.А., Иванова М.М. Синовиальная оболочка при ранней стадии ревматоидного артрита: клинико-морфологические сопоставления. Тер. архив, 2003, 5, 12-20</p><p>Harada М., Mitsuyama К., Yoshida Н. et al. Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand. J. Rheumatol., 1998, 27, 377-380</p><p>Warren R.S., Yuan H., Matti M.K. et al. Regulation by vascular endothelial rowth factor of human colon cancer tumorogenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 1995, 95, 1789-1797</p><p>Насонова В.А., Сигидин Я.А. Базисная терапия ревматоидного артрита в ранней стадии. Тер. архив, 1996, 5, 5-8</p><p>Nagashima М., Yoshino S., Aono Н. et al. lngibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells. Clin. Exp. Immunol., 1999, 116 (2), 360-365</p><p>Nagashima М., Wauke K., Hirano D. et al. Effects of combinations of anti-rheumatic drugs on the prodaction of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. J. Rheumatol., 2000, 39, 1255-1262</p><p>Гусев Д.Е., Сигидин Я.А. К характеристике влияния кортикостероидов на деструкцию суставов при ревматоидном артрите. Клинич. ревматол., 1996, 1, 29-32</p><p>Сигидин Я.А., Лукина Г.В. Базисная (патогенетическая) терапия ревматоидного артрита. М., 2000, 70-83</p></div><br />